Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of st...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f08826ba092240778bfd49fa7117c566 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f08826ba092240778bfd49fa7117c566 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f08826ba092240778bfd49fa7117c5662021-11-25T17:02:41ZRole and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma10.3390/cancers132256902072-6694https://doaj.org/article/f08826ba092240778bfd49fa7117c5662021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5690https://doaj.org/toc/2072-6694Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of studies implicate CT antigens in almost all hallmarks of cancer, suggesting that they may act as cancer drivers. CT antigens are expressed in head and neck squamous cell carcinomas. However, their role in the pathogenesis of these cancers remains poorly studied. Given that CT antigens hold intriguing potential as therapeutic targets and as biomarkers for prognosis and that they can provide novel insights into oncogenic mechanisms, their further study in the context of head and squamous cell carcinoma is warranted.Sharon Changshan WuKarl MüngerMDPI AGarticleCT antigensHNSCCHPVNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5690, p 5690 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
CT antigens HNSCC HPV Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
CT antigens HNSCC HPV Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Sharon Changshan Wu Karl Münger Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma |
description |
Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of studies implicate CT antigens in almost all hallmarks of cancer, suggesting that they may act as cancer drivers. CT antigens are expressed in head and neck squamous cell carcinomas. However, their role in the pathogenesis of these cancers remains poorly studied. Given that CT antigens hold intriguing potential as therapeutic targets and as biomarkers for prognosis and that they can provide novel insights into oncogenic mechanisms, their further study in the context of head and squamous cell carcinoma is warranted. |
format |
article |
author |
Sharon Changshan Wu Karl Münger |
author_facet |
Sharon Changshan Wu Karl Münger |
author_sort |
Sharon Changshan Wu |
title |
Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma |
title_short |
Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma |
title_full |
Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma |
title_fullStr |
Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma |
title_full_unstemmed |
Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma |
title_sort |
role and clinical utility of cancer/testis antigens in head and neck squamous cell carcinoma |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/f08826ba092240778bfd49fa7117c566 |
work_keys_str_mv |
AT sharonchangshanwu roleandclinicalutilityofcancertestisantigensinheadandnecksquamouscellcarcinoma AT karlmunger roleandclinicalutilityofcancertestisantigensinheadandnecksquamouscellcarcinoma |
_version_ |
1718412812107120640 |